Baku 26° C
BioNTech, Pfizer studying new COVID variant
Health
- 26 November, 2021
- 13:30
BioNTech and Pfizer said that experts are studying a new variant of coronavirus discovered in South Africa, more information is expected in two weeks, Report informs.
“We expect more laboratory data in two weeks at the latest,” BioNTech spokesman said, according to Agence France-Presse.
The company stressed that the data will help to understand whether the variant of coronavirus B.1.1.529 could “require a vaccine adjustment” by Pfizer/BioNTech in the event that it spreads worldwide.
Author
Latest News
13:42
President: Azerbaijan prioritizes provision of int'l peace and security
Domestic policy13:39
Coastal cleanup campaign held in Bilgah at Leyla Aliyeva's initiative
Ecology13:31
Ilham Aliyev: Well-conceived security system based on ability to anticipate risks
Domestic policy13:25
Ilham Aliyev: Ensuring peace, stability and security in the world is a shared responsibility of all states
Domestic policy13:18
Ilham Aliyev: AI malicious use creating serious challenges to counter-terrorism efforts
Domestic policy13:08
Temperatures to reach 34 C in Azerbaijan tomorrow
Ecology13:02
Ilham Aliyev addresses participants of 4th Baku Security Forum
Domestic policy12:47
Farid Mammadov: ADEX‑2026 to launch first official merch collection
Military12:30